US Stocks Above 52Week Low and Below 52Week High: $TRUP $ADTX $CELH

*If You Own TRUP, ADTX, CELH Then Click Here to Join Our Community Of Traders

The Market Signal was created as a platform to help investors, if you own (NASDAQ:TRUP), (NASDAQ:ADTX) or (NASDAQ:CELH) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Trupanion Reported Q2-2020 Financial Results

https://themarketsignal.com/Free-Report/TRUP

(Click link above or copy, paste and hit enter in your browser for your report)

Trupanion Inc (NASDAQ:TRUP) is appearing bullish and is trading 257.34% above its 52-Week Low, and 14.22% below its 52-Week high. The company recently reported its second quarter financial results. The total revenue generated by company was reported at $117.9 million, indicating 28% increase when compared to Q2- 2019.

Net income of the company came in at $0.04 per basic and diluted share or $1.4 million as against net loss of $0.06 per basic and diluted share or $1.9 million in Q2- 2019.

Adjusted EBITDA in Q2-2020 totaled at $5.5 million, as against $1.3 million in the Q2- 2019.

Operating cash flow at the end of second quarter was reported at $4.9 million and free cash flow came in at $3.1 million. This compares with the operating cash flow of $2.9 million in the second quarter of previous year, and free cash flow of $2.0 million in Q2-2019.

Aditx Therapeutics Launched AditxtScore(TM) For COVID-19

https://themarketsignal.com/Free-Report/ADTX

(Click link above or copy, paste and hit enter in your browser for your report)

Another bullish stock is ADiTx Therapeutics Inc (NASDAQ:ADTX), which exited the session at 168.55% above its 52-Week Low, and 7.34% below its 52-Week high. Yesterday, the company launched AditxtScore(TM) for COVID-19. It is projected as double-multiplex assay for detection of antibodies in SARS-CoV-2 antigens. This is primarily associated with Palo Alto based Stanford Blood Center in California.

AditxtScore(TM) for COVID-19 shall be used for detection as well as differentiation of different isotypes of antibody against COV antigens in one reaction. Enhanced sensitivity and specificity can result in bringing down the un-clear test results of SARS-CoV-2. AditxtScore(TM) for COVID-19 is therefore seen as an important tool for evaluation of immune responses to the vaccines of SARS-CoV-2.

Celsius Reported Q2-20 And H1-20 Financial Results

https://themarketsignal.com/Free-Report/CELH

(Click link above or copy, paste and hit enter in your browser for your report)

Celsius Holdings, Inc. (NASDAQ:CELH) is presently trading 580.72% above its 52-Week Low, and 29.38% below its 52-Week high. This stock looks bullish. The company recently reported its quarterly and half yearly financial results for the period ending June 30, 2020.

In Q2-2020, the company reported record revenue of $30.0 million, going up 86.3% when compared with $16.1 million in Q2-2019. Gross profit of $13.0 million, up 88.4% from $6.9 million in the year ago quarter

Net income of company totalled at $1.6 million in Q2-2020, while the net loss incurred was $1.5 million in Q2-2019. The company collected Non-GAAP Adjusted EBITDA worth $2.6 million in Q2-2020 relative to $15,000 in Q2-2019.

In H1-2020, the revenue collected by company came in at $58.2 million, moving north 90.2% from H1-2019 when revenue was reported at $30.6 million.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_369031388/2700/2020-08-07T09:17:28

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.